🏢CompaniesJazz Pharmaceuticals Raises 2026 Revenue Outlook Following Record Q3
Jazz Pharmaceuticals reported record third-quarter revenues of $1.24 billion and increased its full-year guidance, citing strong operational execution.
🏢CompaniesJazz Pharmaceuticals reported record third-quarter revenues of $1.24 billion and increased its full-year guidance, citing strong operational execution.
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.